Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Akebia Therapeutics, Inc. (AKBA) vs Siga Technologies Inc. (SIGA)

Akebia Therapeutics, Inc. and Siga Technologies Inc. are both Drug Manufacturers Specialty & Generic companies. Akebia Therapeutics, Inc. and Siga Technologies Inc. are of similar size ($254.7M and $233.5M). Akebia Therapeutics, Inc. grew revenue faster over the last twelve months: 7.52% against −70.1%. Siga Technologies Inc. has the higher net margin (−5.19% vs −13.5%) and the lower return on invested capital (−14.6% vs 0.00%). Across the 19 metrics below, Akebia Therapeutics, Inc. leads on 11 and Siga Technologies Inc. on 8.

Valuation

Metric AKBA SIGA Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.14
P/S 1.11 4.61 2.25
P/B 9.70 1.50 1.90
Price to free cash flow 6.03 n/m 16.54
EV/EBITDA n/m n/m 12.29
EV/Sales 0.62 2.45 2.56
Earnings yield (12.00%) (1.16%) (2.99%)
Free cash flow yield 16.59% (8.29%) 0.00%

Profitability

Metric AKBA SIGA Drug Manufacturers Specialty & Generic median
Gross margin 79.63% 54.35% 53.94%
Operating margin (6.90%) (20.76%) 0.00%
Net margin (13.54%) (5.19%) 0.00%
Free cash flow margin 18.38% (37.58%) 0.00%
Return on equity (109.38%) (1.49%) (0.40%)
Return on assets (8.53%) (1.36%) (3.32%)
Return on invested capital 0.00% (14.59%) 0.00%

Growth

Metric AKBA SIGA Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 7.52% (70.13%) 10.01%
EPS growth (last fiscal year) 93.94% (60.98%) —
Revenue growth, 5-year CAGR (4.33%) (5.42%) 6.74%
Net income growth, 5-year CAGR 0.00% (16.20%) 0.00%

Health

Metric AKBA SIGA Drug Manufacturers Specialty & Generic median
Debt to equity 1.98 0.00 0.05
Current ratio 1.43 21.72 2.31
Net debt to EBITDA (5.51) (6.39) 0.85

Dividend

Metric AKBA SIGA Drug Manufacturers Specialty & Generic median
Dividend yield — 0.00% 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric AKBA SIGA Drug Manufacturers Specialty & Generic median
Market cap 254.66m 233.51m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack